Search
Animal Health Partnering Outlook
Worldwide Contacts Animal Health Partnering May 2024
Animal Health Partnering Interests Cardiometabolic Diseases May 2024 CORP
Animal Health Partnering Interests Infectious Diseases May 2024 CORP
Animal Health Partnering Interests Pain & Mobility May 2024 CORP
Animal Health Partnering Interests CNS Diseases May 2024 CORP
Animal Health Partnering Interests Parasitology May 2024 CORP
Animal Health Partnering Interests Oncology May 2024 CORP
Partnering with Animal Health May 2024 CORP
Animal Health Partnering Interests Immunology & Inflammation May 2024 CORP
Animal Health Partnering Interests Digital Science May 2024 CORP
Animal Health Partnering Interests Technologies May 2024 CORP
Partnering with Animal Health MAY 2024 CORP_0.pdf
Partnering in Oral Health MAY 2024 CORP_0.pdf
Partnering in Mental Health Disorders MAY 2024 CORP _0.pdf
Corporate volunteering boosts social impact - A win for all.
Boehringer Ingelheim corporate volunteers help people with disabilities. Volunteering has social impact and benefits employees, employers, and communities.
Meet our team
Meet our team
Mental Disorders
Mental Disorders
Boehringer Ingelheim Social Engagements
Boehringer Ingelheim Social Engagements Contributes to company commitment to impact 50 million people in vulnerable communities by 2030 through supporting social entrepreneurs and innovative solutions
TwistPak Mixing platform for swine vaccines
TwistPak® allows for fresh mixing of Ingelvac CircoFLEX® and Ingelvac MycoFLEX® on farm in less than 5 seconds
Cat vaccination 10 things you should know
Find out how you can keep your feline companion happy and healthy. We’ve answered 10 important questions about cat vaccination, to help you make informed decisions about preserving your cat’s health.
Approval for Aservo EquiHaler equine asthma therapy
Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy
Three challenges shape future antiparasitic treatment
The three key challenges that will shape the future of antiparasitic treatment
GARC Louis Nel interview on global rabies control
GARC’s Executive Director Professor Louis Nel shares what it takes to fight rabies.